Inhibition of NR5A1 Phosphorylation Alleviates a Transcriptional Suppression Defect Caused by a Novel NR0B1 Mutation

Abstract Context Mutations in the NR0B1 gene, also well-known as the DAX1 gene, are known to cause congenital adrenal hypoplasia associated with hypogonadotropic hypogonadism. The abnormal NR0B1 protein fails to suppress the transcription of promoters of steroidogenic enzymes, which are also targets of NR5A1 protein, also well-known as Ad4BP/SF-1 protein. Since NR5A1 and NR0B1 have antagonistic effects on steroidogenesis, the loss of function due to NR0B1 mutations may be compensated by inducing loss of function of NR5A1 protein. Patient A middle-aged man was diagnosed with congenital adrenal hypoplasia associated with hypogonadotropic hypogonadism and genetic analysis revealed him to have a novel NR0B1 mutation, c.1222C>T(p.Gln408Ter). Methods NR0B1 activity was evaluated in CLK1/4 inhibitor-treated 293T cells via immunoblotting and luciferase assays of the STAR promoter. Results TG003 treatment suppressed NR5A1 protein function to compensate for the mutant NR0B1 showing inhibited suppression of transcription. Immunoblotting analyses showed that the phosphorylation status of NR5A1 at Ser203 was attenuated by the CLK1/4 inhibitor. Conclusion The specific reduction of NR5A1 phosphorylation by a CLK1/4 inhibitor may alleviate developmental defects in patients with NR0B1 mutations.

[1]  Li Li,et al.  Nonsense variant of NR0B1 causes hormone disorders associated with congenital adrenal hyperplasia , 2021, Scientific Reports.

[2]  F. Supek,et al.  To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases. , 2020, Trends in genetics : TIG.

[3]  T. Nonaka,et al.  Identification and Analysis of a Novel NR0B1 Mutation in Late-Onset Adrenal Hypoplasia Congenita and Hypogonadism , 2020, Journal of the Endocrine Society.

[4]  G. Hammer,et al.  Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1 , 2017, Development.

[5]  M. Hagiwara,et al.  Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy , 2017, Scientific Reports.

[6]  Hong Wang,et al.  CRISPR/Cas9-mediated Dax1 knockout in the monkey recapitulates human AHC-HH. , 2015, Human molecular genetics.

[7]  Z. Cai,et al.  A Novel Mutation of DAX-1 Associated with Secretory Azoospermia , 2015, PloS one.

[8]  M. Hagiwara,et al.  Modulation of alternative splicing with chemical compounds in new therapeutics for human diseases. , 2015, ACS chemical biology.

[9]  T. Yanase,et al.  Exendin-4, a GLP-1 Receptor Agonist, Attenuates Prostate Cancer Growth , 2014, Diabetes.

[10]  M. Nakao,et al.  The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2 , 2012, Molecular biology of the cell.

[11]  J. Scheys,et al.  Evidence of adrenal failure in aging Dax1-deficient mice. , 2011, Endocrinology.

[12]  M. Hagiwara,et al.  Chemical treatment enhances skipping of a mutated exon in the dystrophin gene , 2011, Nature communications.

[13]  R. Kuick,et al.  Dax1 up-regulates Oct4 expression in mouse embryonic stem cells via LRH-1 and SRA. , 2010, Molecular endocrinology.

[14]  B. Köhler,et al.  Update--steroidogenic factor 1 (SF-1, NR5A1). , 2010, Minerva endocrinologica.

[15]  H. Yao,et al.  Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog. , 2010, Endocrinology.

[16]  P. George,et al.  Three cases of congenital adrenal hypoplasia with novel mutations in the (NROB1) DAX-1 gene , 2008, Annals of clinical biochemistry.

[17]  N. Hanley,et al.  Deoxyribonucleic acid methylation controls cell type-specific expression of steroidogenic factor 1. , 2008, Endocrinology.

[18]  E. McCabe.  DAX1: Increasing complexity in the roles of this novel nuclear receptor , 2007, Molecular and Cellular Endocrinology.

[19]  M. Shirakawa,et al.  Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. , 2004, Molecular endocrinology.

[20]  Hiroshi Kimura,et al.  Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks* , 2004, Journal of Biological Chemistry.

[21]  E. Lalli,et al.  DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. , 2003, Molecular endocrinology.

[22]  E. Lalli,et al.  X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Jameson,et al.  Phenotypic spectrum of mutations in DAX-1 and SF-1 , 2001, Molecular and Cellular Endocrinology.

[24]  M. Ito,et al.  Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression. , 2001, The Journal of clinical endocrinology and metabolism.

[25]  P. Hindmarsh,et al.  Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. , 1999, The Journal of clinical endocrinology and metabolism.

[26]  T. Yanase,et al.  Dax-1 as one of the target genes of Ad4BP/SF-1. , 1999, Molecular endocrinology.

[27]  P. Hindmarsh,et al.  A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans , 1999, Nature Genetics.

[28]  P. Kopp.  Targeted disruption of the Ahch (Dax-1) gene: knockout of old concepts. , 1999, European journal of endocrinology.

[29]  P. Donohoue,et al.  Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. , 1999, The Journal of clinical endocrinology and metabolism.

[30]  S. Camper,et al.  Role of Ahch in gonadal development and gametogenesis , 1998, Nature Genetics.

[31]  J. Milbrandt,et al.  Nuclear Receptor DAX-1 Recruits Nuclear Receptor Corepressor N-CoR to Steroidogenic Factor 1 , 1998, Molecular and Cellular Biology.

[32]  T. Strom,et al.  A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. , 1997, Molecular endocrinology.

[33]  M. Ito,et al.  DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita , 1997, Molecular and cellular biology.

[34]  M. Kiriakidou,et al.  Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene. , 1996, Biochemistry.

[35]  J. Milbrandt,et al.  Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Monaco,et al.  Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism , 1994, Nature.

[37]  A. Monaco,et al.  An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita , 1994, Nature.

[38]  K. Parker,et al.  A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation , 1994, Cell.

[39]  H. Handa,et al.  A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. , 1992, The Journal of biological chemistry.

[40]  K. Parker,et al.  Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. , 1992, Molecular endocrinology.

[41]  G. Hammer,et al.  Regulation of the adrenocortical stem cell niche: implications for disease , 2015, Nature Reviews Endocrinology.

[42]  Jun-Fen Fu,et al.  Novel mutations in DAX1 of X-linked adrenal hypoplasia congenita over several generations in one family. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[43]  A. Lewis,et al.  Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7. , 2008, Molecular endocrinology.

[44]  E. Lalli,et al.  DAX-1 blocks steroid production at multiple levels. , 1998, Endocrinology.